Pharmaceutical Industry

Roche Sapac AG 

Basel · Since 2022

Rocketvax AG 

Basel · Since 2019

The core activity of RocketVax AG is the development and research of vaccines, particularly against Covid-19. The company focuses on developing vaccines that guarantee better immunity and can be easily administered through the nose. It is also working on improving Corona vaccine protection and plans to develop new vaccines.

RUBIMED AG 

Hergiswil Nw · Since 1998

The core activity of Rubimed AG is the development, dissemination and support of Psychosomatic Energetics (PSE), an alternative medical method that focuses on the treatment of diseases and complaints through the combination of scientific knowledge, psychology, homeopathy and Far Eastern energy doctrine. The company provides information, materials and support for therapists and patients who apply or wish to apply this method.

RXcel GmbH 

Basel · Since 2023

RXcel GmbH develops RNA-based therapeutics for oncology that use engineered RNA molecules to detect cancer cells by the absence of specific genetic markers and to trigger selective therapeutic effectors. The company focuses on conditional-stability RNA designs targeting glioblastoma and reports in vitro/preclinical data alongside academic collaborations on its website.

Boehringer Ingelheim Veterinary Medicine Switzerland AG 

Zurich · Since 2024

Saiba X AG 

Pfäffikon Sz · Since 2024

Salmon Pharma GmbH 

Basel · Since 1982

The company's core activity is the development, production and distribution of pharmaceuticals, particularly in the areas of ADHD, anemia, nephrology and urology. The company specializes in the manufacture of medications that aim to improve the quality of life for patients.

Salus Schweiz AG 

Pfäffikon Sz · Since 2020

The core activity of Salus Schweiz AG is the development, manufacture and distribution of health products, in particular tonics, teas, elixirs, tablets and other plant-based products.

SANOFI GESTION SA 

Vernier · Since 1993

SANOFI GESTION SA is a healthcare and pharmaceutical company supplying therapeutic solutions, vaccines and health products. Its activities include immunology, rare diseases, oncology, neurology, general medicines and consumer health.

Santen SA 

Geneva · Since 2014

The company's core activity is the development, manufacture and marketing of pharmaceutical products in the field of ophthalmology, with the aim of developing innovative and effective solutions for the treatment of eye diseases and providing added value to patients and society.

Santhera GmbH 

Buchs Sg 3 · Since 2001

The core activity of Santhera Pharmaceuticals is the development and marketing of therapeutic solutions for rare and life-threatening diseases. The company focuses on researching and developing medications to improve the lives of patients with these diseases.

Sarepta International Holdings GmbH 

Zug · Since 2017

The core activity of Sarepta Therapeutics is the development and manufacturing of gene therapies for the treatment of rare diseases, particularly muscular dystrophies such as Duchenne muscular dystrophy, limb-girdle muscular dystrophy (LGMD), and Charcot-Marie-Tooth disease. The company focuses on researching and developing precision gene medicine and aims to increase efficiency in drug development and shorten the time from laboratory to patient.

saverna therapeutics AG 

Biel-Benken Bl · Since 2017

The core activity of Saverna Therapeutics is the discovery and development of small, orally active molecules targeting non-coding RNA biology to treat diseases with unmet medical needs. The company utilizes a platform based on artificial intelligence and nuclear magnetic resonance to reduce the time and cost of drug development.

Scalepharm AG 

Baar · Since 2019

The core activity of Scalepharm is the development, registration, manufacture and marketing of generic finished medicinal products, in particular prescription-only medicines, which are distributed through retail pharmacies and hospitals.

Schülke & Mayr AG 

Frauenfeld · Since 1994

The core business of Schülke & Mayr GmbH is the development, manufacture and marketing of products and solutions for infection prevention, hygiene and preservation, particularly in the healthcare sector.

Schwabe Pharma AG 

Küssnacht Am Rigi · Since 1992

The company's core activity is the production and distribution of homeopathic and herbal remedies.

Schweizer Blisterzentrum AG 

Zurich · Since 1986

The Swiss Blister Centre is a company specializing in the blister packaging of medications. The core activity of the company is to manufacture individually portioned medications for patients to increase safety when taking medications. The company offers a modern production facility where medications are packaged to enable patients to receive safe and individualized medication administration.

Seegpharm SA 

Lugano · Since 2012

Seegpharm SA develops and out-licenses complex generic pharmaceuticals through product co‑development. The company outsources development work including API synthesis‑route development and finished‑dosage‑form development, manages patent freedom‑to‑operate analyses and regulatory registrations, and undertakes selected promotion and distribution activities.

Seito Biologics AG 

Küsnacht Zh · Since 2023

The core activity of SEITO Biologics is the development of innovative, targeted immunotherapies, in particular selective Treg cell engagers (TREX), aiming to restore balance to the immune system in patients with autoimmune and inflammatory diseases.

Selmod GmbH 

Basel · Since 2016

The core activity of Selmod is the development of innovative antibiotics for the treatment of life-threatening, multi-resistant infections. The focus is on the discovery and early clinical development of small molecules and peptides against new target molecules or new mechanisms of action on established or validated target molecules.